Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

varicella-

varicella- is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 16
News articles 0
Drug details — varicella-
Class
—
Route
—
Patents
0
Programs
16
Data quality
0.70
← All drugs Search patents Pipeline programs Drug news hub Event calendar

Quick answer

varicella- is an FDA-listed pharmaceutical active ingredient.

Key facts

INN varicella-

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 213997 (VNS 20-001) Phase 3 · GSK Glaxo Smith · Varicella
  2. 213998 (VNS 20-002) Phase 3 · GSK Glaxo Smith · Varicella
  3. 214002 (VNS 20-004) Phase 3 · GSK Glaxo Smith · Varicella
  4. 223105 Phase 3 · GSK Glaxo Smith · Varicella
  5. Oka strain varicella attenuated live vaccine Phase 3 · Chinese Academy of · Chickenpox Vaccines
  6. PRO-VZV-4002 Phase 3 · Sinovac Research and · Varicella
  7. PROVARIX Phase 3 · Sinovac Research and · Varicella (Chickenpox)
  8. Vaccine manufactured at commercialized scale Phase 3 · Sinovac Research and · Varicella

Frequently asked questions

What is varicella-?

varicella- is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.